|
Lilly's News Release March 23
|
4
|
Resverlogix Corp.
|
Mar 27, 2020 02:43PM
|
|
Re: DSMB
|
4
|
Resverlogix Corp.
|
Feb 21, 2019 06:49PM
|
|
Re: Resverlogix Receives Approval From Health Canada To Proceed With Fabry Disease Clinical Trial With Lead Compound Apabetalone
|
4
|
Resverlogix Corp.
|
May 30, 2017 12:47PM
|
|
Re: Shares and Warrants to be listed on TSX June 7th
|
4
|
Resverlogix Corp.
|
Jun 06, 2019 04:20PM
|
|
Re: The risk of submitting questionable data to the FDA
|
4
|
Resverlogix Corp.
|
Aug 06, 2019 02:43PM
|
|
Re: DSMB 5 postitive recomendation
|
4
|
Resverlogix Corp.
|
Nov 01, 2017 10:56AM
|
|
Re: Saw these articles that might be relevant to us,...
|
4
|
Resverlogix Corp.
|
Sep 20, 2018 02:24PM
|
|
Madrid
|
4
|
Resverlogix Corp.
|
Jun 03, 2017 07:39PM
|
|
Re: Targeting Transcription Factors for Cancer Treatment
|
4
|
Zenith Epigenetics
|
Jun 27, 2018 12:03AM
|
|
Re: Resverlogix Announces FDA Confirmation Regarding Filing Pathway for Apabetalone
|
4
|
Resverlogix Corp.
|
Jun 16, 2018 01:37AM
|
|
Re: TNBC no longer active?
|
4
|
Zenith Epigenetics
|
Jun 28, 2023 04:32PM
|
|
A Bio investor must
|
4
|
Resverlogix Corp.
|
Mar 04, 2024 01:20PM
|
|
Re: ... IT'S ABOUT TIME...!!!!!!!!!!!
|
4
|
Resverlogix Corp.
|
Nov 23, 2017 10:48AM
|
|
Re: Apabetalone - Could the problem be too much potential?
|
4
|
Resverlogix Corp.
|
May 29, 2017 01:23AM
|
|
Re: Debenture Due Friday the 13th, May 2022
|
4
|
Resverlogix Corp.
|
Mar 07, 2022 12:26AM
|
|
Re: The Time Is Ripe!
|
4
|
Resverlogix Corp.
|
Feb 23, 2019 06:25PM
|
|
Re: Que sera sera....
|
4
|
Resverlogix Corp.
|
Mar 30, 2018 01:50PM
|
|
Just an off the wall thought
|
4
|
Resverlogix Corp.
|
May 30, 2019 02:43PM
|
|
Re: Seeming lack of interest
|
4
|
Resverlogix Corp.
|
Sep 12, 2019 03:57AM
|
|
Re: Resverlogix Announces Participation at Prominent Industry and Investor Conferences
|
4
|
Resverlogix Corp.
|
Mar 11, 2019 09:29AM
|
